T1	Intervention 477 636	Patients treated with intravenous betalactam and tobramycin were randomly allocated to receive aerosolized tobramycin (6 mg/kg/day, n = 21) or placebo (n = 17)
T2	Intervention 638 714	The aerosol was administered via a pneumatic nebulizer once a day for 5 days
